Fatigue randomized controlled trials - How tired is "too tired" in patients undergoing glioma treatment?

Neuro-Oncology

Volumn 18, Issue 6, 2016, Pages 759-760

  Grant, Robin ^a   Brown, Paul D ^b  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ARMODAFINIL; STEROID;

BRAIN TUMOR; CANCER RADIOTHERAPY; CHEMORADIOTHERAPY; DISEASE SEVERITY; DISTRESS SYNDROME; DRUG EFFECT; EDITORIAL; FATIGUE; GLIOMA; HUMAN; INSOMNIA; MAJOR DEPRESSION; NEUROLOGIC DISEASE; PREVALENCE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SADNESS;

FATIGUE; GLIOMA; HUMANS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84975132408     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/now052     Document Type: Editorial

References (14)

1. Laura MacDonald for the Neuro-Oncology Group. Top 10 priorities for clinical research in primary brain and spinal cord tumours. http://www.neuro-oncology.org.uk/jla/docs/JLA-PSP-in-Neuro-Oncology-Final-Report-June-2015.pdf.
2. Kos D, Kerckhofs E, Nagels G, et al. Origin of fatigue in multiple sclerosis: review of the literature. Neurorehabil Neural Repair. 2008; 22:91. originally published online April 4, 2007.
3. Armstrong TS, Cron SG, Bolanos EV, et al. Risk factors for fatigue severity in primary brain tumor patients. Cancer. 2010;116(11): 2707-2715.
4. Lee EQ, Muzikansky A, Drappatz J, et al. A randomized, placebo-controlled pilot trial of armodafinil for fatigue in patients with gliomas undergoing radiotherapy. Neuro-Oncol. 2016;18(6):849-854.
5. Day J, Yust-Katz S, Cachia D, et al. Interventions for the management of fatigue in adults with a primary brain tumour. Cochrane Database Syst Rev. 2016 (in press).
6. Boele FW, Douw L, de Groot M, et al. The effect of modafinil on fatigue, cognitive functioning, and mood in primary brain tumor patients: a multicenter randomized controlled trial. Neuro Oncol. 2013;15(10):1420-1428.
7. Butler JM, Case LM, Atkins J, et al. A phase III, double-blind, placebo-controlled prospective randomized clinical trial of d-threo-methylphenidate HCl in brain tumor patients receiving radiation therapy. Int J Radiat Oncol Biol Phys. 2007;69(5): 1496-1501.
8. Gehring K, Sitskoorn MM, Gundy CM, et al. Cognitive rehabilitation in patients with gliomas: a randomized, controlled trial. J Clin Oncol. 2009;27(22):3712-3722.
9. Gehring K, Patwardhan SY, Collins R, et al. A randomised trial on the efficacy of methylphenidate and modafinil for improving cognitive functioning and symptoms in patients with a primary brain tumor. J Neurooncol. 2012;107(1):165-174.
10. Kaleita TA, Wellisch DK, Graham CA, et al. Pilot study of modafinil for treatment of neurobehavioral dysfunction and fatigue in adult patients with brain tumors. J Clin Oncol. 2006;24(18S):1503.
11. Lee E, Muzikansky A, Kesari S, et al. A randomized, placebocontrolled pilot trial of armodafinil for fatigue in patients with gliomas undergoing radiotherapy. Neuro Oncol. 2014;16(suppl 5):v206.
12. Locke DEC, Cerhan JH, Wu W, et al. Cognitive rehabilitation and problem-solving to improve quality of life of patients with primary brain tumors: a pilot study. J Support Oncol. 2008;6(8): 383-391.
13. Shaw EG, Rosdhal R, D'Agostino RB, et al. Phase II study of donepezil in irradiated brain tumor patients: effect on cognitive function, mood, and quality of life. J Clin Oncol. 2005;24(9): 1415-1420.
14. Page BR, Shaw EG, Lu L, et al. Phase II double-blind placebocontrolled randomized study of armodafinil for brain radiation-induced fatigue. Neuro Oncol. 2015;17(10):1393-1401.